Out-of-Pocket Costs of Chikungunya in Travelers: The 2022-2023 Paraguay Outbreak
Travelers contracting chikungunya in Paraguay incurred relatively low direct medical costs but experienced substantial indirect economic losses. Productivity losses and non-refundable expenses underscore the economic toll of this illness extending well beyond immediate healthcare costs.
Authors
- Tyler Y. Headley (ORCID: https://orcid.org/0000-0002-8934-0102)
- Susana Cristina Lloveras (ORCID: https://orcid.org/0000-0003-0707-2560)
- Diana Pou Ciruelo
- Ralph Huits
- Marta Díaz-Menéndez
- Fernando Calle-Prieto
- Yesim Tozan
- Federico G Gobbi
- Hannah Emetulu
- Sofia Elena Echazarreta
- Daniel Camprubí-Ferrer
- Davidson H Hamer
Institutions
- Boston University (US)
- Hebron University (PS)
- Boston Medical Center (US)
- Brescia University (US)
- Departament de Salut (ES)
- Ospedale Sacro Cuore Don Calabria (IT)
- Hospital La Paz Institute for Health Research (ES)
- Hospital Clínic de Barcelona (ES)
- Hospital Muñiz (AR)
- Barcelona Institute for Global Health (ES)
- Hirose Electric (Japan) (JP)
- New York University (US)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Journal of Travel Medicine
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1093/jtm/taag019
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00